Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits ...

There are many different ways to fight aging -- by changing your diet, staying out of the sun or getting good sleep. A new ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its Phase Ib/II study of ...

The New York Department of State is warning consumers to be cautious about seeking “med spa” services from unlicensed ...

AI has just detonated one of the largest funding announcements in the history of artificial intelligence, pairing a $20 ...

Biogen and Eisai recently announced that Chinese regulators have accepted their Biologics License Application for a ...

A new study published in the Pakistan Journal of Pharmaceutical Science showed that when used as an adjuvant treatment for ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...